Adherium

16 articles about Adherium

• Adherium and Summatix Announce Strategic Initiative to Enhance Hailie™ Solution’s Digital Platform Impact

  8/20/2019

  Leading respiratory medical device company Adherium has unveiled its new strategic data-based initiative with Summatix Pty Ltd, with the objective of enabling clinicians globally to enhance their care of patients with asthma and chronic obstructive pulmonary disease.

• Adherium Announces Participation in SmartAirLA Effort to Combat Asthma in Los Angeles with Support from Blue Shield of California FoundationThe Program Aims In Part to Develop Better Models for Expanding Data-Based Medication Adherence

  10/3/2018

  Adherium today announced its participation in the launch of the SmartAirLA program to empower communities to reduce the effects and prevalence of asthma in Los Angeles through Internet of Things technology.

• Holistic digital health for asthma and COPD patients using the Hailie™ Solution

  9/19/2018

  Adherium’s range of Hailie™ sensors and software platform fits into patients’ daily routines and aids in effective medicine management for asthma and COPD, enabling patients, parents and caregivers to worry less about the condition.  

• Adherium Names Tim Houchin Vice President of Sales

  1/26/2018

  The addition of a senior executive of Tim’s caliber is another proof point as we advance our strategy to meet U.S. demand

• Adherium Appoints Vice President Of Marketing

  10/11/2017

• Adherium Appoints New CFO

  9/19/2017

• Adherium Releases Next Generation Adherence Monitor, Smartturbo Model 4, For AstraZeneca PLC’s Turbuhaler

  9/15/2017

• Adherium Snags FDA Clearance for Next Generation Smartinhaler for AstraZeneca PLC's Symbicort Aerosol Inhaler

  9/1/2017

• Adherium Hits 100,000 Smartinhaler Commercial Milestone

  8/16/2017

• Adherium Appoints New CEO To Drive Global Growth

  6/9/2017

• Adherium Appoints New CEO To Drive Global Growth

  6/9/2017

• Independent Clinical Study Shows Adherium’s Smartinhaler Dramatically Improves Clinical Outcomes And Medication Adherence In Children With Asthma

  11/17/2016

• Adherium Expands Its International Presence Announces Mr Thomas Lynch As Chairman And Dr Doug Wilson As Medical Director

  9/1/2016

• Adherium Executes $8 Million Share Placement To Fidelity International

  7/20/2016

• Adherium Establishes North American Operations And Appoints Senior Vice President Of Business Development To Lead Market Expansion

  4/19/2016

• Adherium Appoints Senior Executive To Lead Market Expansion And Establishes European Operations

  4/4/2016